# A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

> **NCT06143891** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Sanofi** · enrollment: 260 (estimated)

## Conditions studied

- Chronic Graft Versus Host Disease

## Interventions

- **DRUG:** Belumosudil
- **DRUG:** Placebo
- **DRUG:** Prednisone
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT06143891
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-23
- **Primary completion:** 2028-09-29
- **Final completion:** 2028-09-29
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143891, "A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06143891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*